Biotech News

Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026

Nautilus Biotechnology (NAUT)Nautilus BiotechnologyEarnings

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the third quarter 2026 before market open on Tuesday, October 27, 2026.

Related news

Nautilus Biotechnology

Single-Molecule Proteomics Platform Nautilus Biotechnology is a development-stage life sciences company building a single-molecule proteomics platform intended to make comprehensive protein analysis more accessible. The platform is designed to quantify proteins and their proteoforms at scale, supporting research in disease biology,...

Recent company news

Stock data

Close
2.17 USD
Market cap
340.57M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States